GB2232769A - Counting, volume and deformability measurement of particles and biological cells - Google Patents
Counting, volume and deformability measurement of particles and biological cells Download PDFInfo
- Publication number
- GB2232769A GB2232769A GB8913593A GB8913593A GB2232769A GB 2232769 A GB2232769 A GB 2232769A GB 8913593 A GB8913593 A GB 8913593A GB 8913593 A GB8913593 A GB 8913593A GB 2232769 A GB2232769 A GB 2232769A
- Authority
- GB
- United Kingdom
- Prior art keywords
- pore
- particles
- electrode
- membrane
- deformability
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002245 particle Substances 0.000 title claims abstract description 66
- 238000005259 measurement Methods 0.000 title description 9
- 239000011148 porous material Substances 0.000 claims abstract description 103
- 239000012528 membrane Substances 0.000 claims abstract description 32
- 239000007788 liquid Substances 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims description 19
- 239000000725 suspension Substances 0.000 claims description 5
- 238000000609 electron-beam lithography Methods 0.000 claims description 4
- 239000012777 electrically insulating material Substances 0.000 claims description 3
- 239000008151 electrolyte solution Substances 0.000 claims description 3
- 239000000243 solution Substances 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 2
- 210000004027 cell Anatomy 0.000 description 49
- 210000003743 erythrocyte Anatomy 0.000 description 9
- 210000000601 blood cell Anatomy 0.000 description 8
- 230000008859 change Effects 0.000 description 8
- 239000003792 electrolyte Substances 0.000 description 6
- 230000008901 benefit Effects 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 210000000265 leukocyte Anatomy 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 230000036619 pore blockages Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000004513 sizing Methods 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 201000004569 Blindness Diseases 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005534 acoustic noise Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000002296 dynamic light scattering Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- XULSCZPZVQIMFM-IPZQJPLYSA-N odevixibat Chemical compound C12=CC(SC)=C(OCC(=O)N[C@@H](C(=O)N[C@@H](CC)C(O)=O)C=3C=CC(O)=CC=3)C=C2S(=O)(=O)NC(CCCC)(CCCC)CN1C1=CC=CC=C1 XULSCZPZVQIMFM-IPZQJPLYSA-N 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920006289 polycarbonate film Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 208000007056 sickle cell anemia Diseases 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/1031—Investigating individual particles by measuring electrical or magnetic effects
- G01N15/12—Investigating individual particles by measuring electrical or magnetic effects by observing changes in resistance or impedance across apertures when traversed by individual particles, e.g. by using the Coulter principle
- G01N15/134—Devices using two or more apertures
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/01—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials specially adapted for biological cells, e.g. blood cells
- G01N2015/012—Red blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N2015/1022—Measurement of deformation of individual particles by non-optical means
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N2015/1024—Counting particles by non-optical means
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N2015/103—Particle shape
Landscapes
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
Abstract
An apparatus for counting particles and for determining their volume and deformability comprises: - a membrane (10) having a first reservoir (18) on one side thereof containing a first electrode (20) and a second reservoir (22) on the other side thereof containing a second electrode (24); - the membrane (10) having a plurality of pores (12) therethrough, which provide in use the only means for establishing electrical continuity between the first and second electrodes via electrically conductive liquid contained in the reservoirs, each pore comprising a first portion leading into a second portion; and - a respective third electrode located at the junction of the first and second portions of each pore. The changes in electrical potential sensed at the respective third electrodes are indicative of the presence of a particle within the pore, the size of the particle, and its transit time within each portion of the pore. The portions may be of equal length and diameter or different. The resistance of any portion is sufficient to provide a measurable voltage drop between the third electrode and both the first and second electrodes when no particle is present. <IMAGE>
Description
COUNTING AND VOLUME MEASUREMENT OF PARTICLES AND BIOLOGICAL
CELLS, AND DETERMINATION OF THEIR DEFORMABILITY.
The present invention relates to an apparatus for counting, measuring the size, and determining the deformability of particles and biological cells suspended in a fluid. In particular, the apparatus allows for accurate counting and size measurement of particles in the size range from 10 nanometres upwards, using an adaptation of the known aperture impedance principle, and makes possible a high degree of noise elimination and reducing the problem of aperture blockage. The apparatus also provides an advantageous means to measure the deformability'of inert particles and blood cells (both red and white blood cells) by measuring the time taken to pass through individual micropores.
The aperture impedance technique for counting and sizing particles suspended in electrolyte was first described in 1949 (W.H.Coulter US Patent 2656508). Since then the principle has been developed and refined and it is now the most commonly-used technique for the counting and sizing of particles of all descriptions. For accurate sizing, the diameter of the particle must lie between 2 and 60% of the aperture diameter. The smallest apertures used are typically 15 micrometres in diameter. The minimum size of particle that can be resolved using standard equipment is currently about 0.3 micrometres diameter. This limitation is mostly due to electrical
i noise and vibration (or acoustic noise) both of which generate baseline fluctuations which obscure the signal from smaller particles.Another important practical difficulty, especially for small particles, is that the small apertures are particularly prone to repeated blockage by large particles, particle aggregates or debris. Some specialised equipment has been constructed which uses a single sub-micrometre pore to measure the size and electophoretic mobility of particles down to 15 nanometres (DeBlois RW, Bean CP and Wesley RKA, J. Colloid and Interface Science, 61 (2) pp. 323-335 1977), but this also is affected by the foregoing disadvantages, particularly pore blockage.
Measurement of particles in the nanometre size range is essential in the control of industrial processes.
Variation in the size of particles of ceramics, metal oxides, pigments, toners, powders, dyes, plastics, photographic materials etc. will all influence manufacturing processes and the characteristics of the final product. The stability of colloids depends critically upon particle size. Particles in the size range 5nm to 1 micron are most commonly measured nowadays by light scattering techniques, particularly photon correlation spectroscopy, which are error prone, give little information about particle size distribution, and require immense computing power. Such instrumentation is complex and expensive. It would be a particular advantage to be able to extend the much simpler aperture impedance technique to the measurement of particles in this range.
Red blood cells are disc-shaped cells with a diameter of 7-8 micrometres. Their surface area is approximately 1.5 times greater than the minimum required to enclose their internal volume. This characteristic optimises the rate of oxygen transfer through the cell membrane and also contributes to their particular flexibility, or deformability. The deformability of red blood cells contributes to the ease with which blood flows in all blood vessels, but is of vital importance for flow in the smallest blood vessels in the body, the capillaries, which may have dimensions of 5 micrometres or less (i.e. very much smaller than red blood cells). Thus, the deformable nature of the cells is essential to permit blood flow through capillary networks to deliver oxygen to the tissues they supply.
Abnormal red blood cell rigidity is described in many diseases. Of particular interest are sickle cell anaemia and diabetes. In the former condition changes in deformability are of abrupt onset, with the cells changing to a rigid "sickle" shaped state. Blood flow in capillary networks is obstructed because the cells will no longer deform, causing extreme pain and tissue damage which may be severe. By contrast, the deformability change in diabetes is much less marked, but is chronic. The major debilitating complications of diabetes; blindness and kidney failure, which develop slowly over period of years are known to result from capillary damage. Reduced red blood cell deformability, with consequent reduction to delivery of oxygen and nutrients, is believed to have a central role.
White blood cells though much fewer in number, are larger and much more rigid than red blood cells and consequently pass with even more difficulty through the smallest capillaries. Again, excessive white blood cell rigidity has been described in diabetes and also stroke.
Studies of red blood cell and white blood cell deformability in these and other disorders not only help to pinpoint the pathological processes involved, but are invaluable in the evaluation of drug treatments.
Numerous methods exist for the measurement of blood cell deformability. The various principles can be conveniently divided into two groups, (a) those which measure the average properties of a large number of cells and (b) those which make individual measurements on the cells.
(a) The main technique in this category is the filtration
of a cell suspension through filters containing a
large number (105 or more) of pores of smaller
diameter than the cells ( Leblond PF and Coulombe L,
Scand. J. clin. Lab. Invest. 41, Suppl.156, pp.35-40
1981). The deformability is assessed by measuring
either the flow rate of the suspension or the pressure
required to force the cells through the filter. The
technique is simple, but is incapable of detecting the
presence of subpopulations of more or less rigid
cells. Variation of pore size and pore coincidence
(even with the best commercially available filters)
reduces precision.
The other technique of note is the measurement of the
diffraction of a spot of light passed through a
sheared suspension of blood cells (see Bess is M, and
Mohandas N, Blood cells, 1, 307-313,1975). The
shearing forces deform the cells, which diffract the
light differently according to their state of
deformation. Again, subpopulations cannot be
discriminated.
(b) The standard method for measuring individual cell
flexibilities is to aspirate each individual cell into
a micropipette having an aperture smaller than the
cell (Evans E. Biophys J., 30, 265-284, 1980).
Deformability is assessed by observing the amount of
cell membrane aspirated at a given pressure, or by
measuring the transit time through the pipette
aperture. In an equivalent technique (Keisewetter H,
et al, Scand. J. Clin. Lab. Invest. 41, Suppl. 156,
pp.229-232, 1981), the transit time of cells through a
single minute pore in a membrane is measured. These
techniques are more precise because only one aperture
is used, and subpopulations of rigid cells may be
identified. However, the disadvantage is that cells
are aspirated a1 individually so it takes a long time to obtain sufficient data for analysis. Also, the membranes are expensive to produce and the single pore is repeatedly blocked by debris or leucocytes.An improvement upon this method is to measure the transit times of cells through a membrane with a larger number of pores (30 to 50), these transit times being measured by detecting the change in overall electrical resistance of the membrane as the cells pass through (Koutsouris
D, et al, Biorheology, 25r pp 763-772, 1988). The technique is also described in British Patent specification 2163555. The advantages are that each cell transit is detected individually and that data is acquired much faster than with the micropipetting technique. There are several disadvantages: i) Coincident or nearly-coincident passage of two or more cells through different pores gives rise to a spurious value for transit time - therefore cell suspensions must be very dilute to ensure that this is a rare event, and data from such events, if identifiable, must be rejected.
ii) Pore blockage (or cells with very long transit times) causes a shift in the baseline conductivity which will be superimposed on the transits of other cells.
iii) The pores vary in size. The microporous filters used are made by the track/etch technique i.e.
irradiation of polycarbonate film by energetic
particles, causing weakening of the structure along
tracks, followed by etching along these tracks to
produce holes of the correct dimensions. The random
nature of the process results in a certain degree of
pore coincidence, and the diameters of the pores have
quite a wide degree of variation in diameter.
Consequently, the transit times even of identical
cells will vary if passing through different pores.
It is an object of the present invention to mitigate these disadvantages.
The present invention provides an apparatus for counting particles and for determining their volume and deformability which comprises:
- a membrane having a first reservoir on one side
thereof containing a first electrode and a second
reservoir on the other side thereof containing a
second electrode
- the membrane having a plurality of pores there
through, which provide in use the only means for
establishing electrical continuity between the first
and second electrodes via electrically conductive
liquid contained in the reservoirs, each pore
comprising a first portion leading into a second
portion; and
- a respective third electrode being located at the
junction of the first and second portions of each pore, in use the changes in electrical potential sensed at the respective third electrode being indicative of the presence of a particle within the pore, the size of the particle, and its transit time within each portion of the pore. When the particle size exceeds the pore size, the transit time provides an indication of the deformability of the particle.
As used herein, the term "membrane" means a thin sheet of rigid or flexible electrically insulating material or a composite sandwich of two or more such materials. The term "particle" is to be interpreted to include not only rigid particles but also deformable particles, such as cells.
The purpose of the first and second portions of the pore, with the third electrode positioned at the junction of these portions, is to create an electrical resistance between the first and third electrodes, and between the third and second electrodes. Generally, the particles and cells have a much lower electrical conductivity than the electrically conductive liquid (for example electrolyte solution) in which they are suspended. When the particle enters the first pore portion, the electrical resistance between the first and third electrodes increases thereby varying the voltage at the third electrode; a constant voltage being applied between the first and second electrodes.Continued passage of the particle into the second pore portion increases the electrical resistance between the third and second electrodes so varying again the voltage sensed at the third electrode, but in the i opposite sense. It is of particular significance that the changes in resistance occurring in any one pore or region thereof can have no influence on any other pore in the membrane, thus all pores are both electrically and physically independent of any other. Generally, the electrical resistances in the two pore portions in the absence of a particle will be arranged to be approximately equal, but this is not essential - the only absolute requirement is that the resistance of any portion is sufficient to provide a measurable voltage drop between the third electrode and both the first and second electrodes when no particle is present.This may be achieved by making the pore portions of equal length and diameter. Alternatively, the first pore could be narrower and shorter, whilst the second pore portion is wider and longer. This latter arrangement is particularly useful for the simultaneous measurement of blood cell size and deformability, when the transit time of the cell through the narrow first pore portion gives an indication of the cell deformability, whilst the change in electrical resistance in the second pore portion is proportional to the volume of the cell.
The membrane is generally formed from a sandwich of two electrically insulating materials between which are sandwiched the third electrodes and their associated leads. The third electrodes and the pores may be fabricated by electron beam lithography. One means to form the membrane is to prepare the third electrodes and leads on the surface of a thin glass sheet by electron beam lithography, to lay over these a coating of an etchable polymer, for example polyamide, through which the first portion of the pores is made (again by electron beam lithography) and finally to etch connecting channels through the glass to form the second portion.
For most applications, the number of pores in the membrane is in the region 10-100. Because the pores are physically and electrically independent, the maximum number of pores is limited only by the practical considerations of making electrical connections to the third electrodes and analysing the resulting signals. Thus, a membrane with thousands of pores is feasible. In fact, it is not necessary to actually use all of the pores present, any number may be left unconnected. Similarly, pores can be ignored or disconnected if they become blocked.
Generally, the same electrically conductive liquid will be placed in both reservoirs. For the analysis of biological cells, this solution will be such as to maintain the cells intact and substantially unchanged.
The invention also relates to a corresponding method for counting particles and for determining their volume and deformability in which:
- a suspension of the particles or cells in a suitable
conducting electrolyte solution is placed in one or
other of the reservoirs, with identical particle-free
solution placed in the other;
- a pressure difference is applied across the membrane
to induce the flow of the liquid containing the
suspended particles or cells into and through the
pores (this pressure depends upon the application, but
is typically in the range of 0.1 to 30 millibar);;
- the electrical potentials sensed at the respective
third electrodes are fed into a signal processing
device programmed to extract relevant parameters
according to the particular application (such as
transit times and voltage changes) and to convert
these into the number of particles and their volumes,
or the size and deformability of cells.
An embodiment of the present invention will now be described by way of example only with reference to the accompanying drawings wherein;
Figure 1 is an enlarged schematic cross-sectional view of a single pore
Figure 2 is a schematic cross-sectional view of the apparatus including five membrane pores;
Figure 3 is a representation of the electrically equivalent circuit to each pore;
Figure 4 indicates a typical voltage trace between the third and second electrodes as a blood cell passes through the pore; and
Figure 5 indicates an electrically equivalent circuit for the five pore apparatus of Figure 2.
The membrane shown in Figure 1 comprises a thin sheet of rigid or semi-flexible electrically insulating membrane 10. The membrane may be formed of a single sheet or a composite sandwich of two or more sheets of the same or different materials. A pore 12 passes through the membrane and comprises a first portion A and a second wider and longer portion B. At the junction of portions A and B is arranged a third electrode 14 and conductive lead 16. The dimensions of each of the two portions of the pore are chosen with regard to the ratio of length to a cross-sectional area, such that the resistances Ra and Rb are of the same order of magnitude.
Figure 2 shows the whole apparatus comprising the membrane 10 and five pores 1 to 5 therethrough, each having its respective output lead 16. The membrane separates a first electrolyte reservoir 18 containing a first electrode 20 from a second electrolyte reservoir 22 containing a second electrode 24. The only electrical contact between the reservoirs is via the membrane pores.
Figure 3 shows the electrically equivalent circuit to each single pore. In use, a voltage Vin is applied across the first and second electrodes 20,24. In the absence of a particle in the pore, the resistance Ra of the first pore portion is substantially the same as resistance Rb of the second pore portion, such that Vout is approximately half Vim. The electrically equivalent circuit for the five pore membrane shown in Figure 2 is given in Figure 5.
The fundamental advantage of this arrangement is that events occurring at each pore can be recorded individually, and that each pore is electrically independent of any other.
Operation
In use, an appropriate voltage, for example 5 volts, is applied between the electrodes in each reservoir as described above. A suspension in electrolyte of the particles to be analysed is introduced into one of the reservoirs, 18, and is aspirated under a pressure between -0.1 to -30 millibar, for example -5 millibar, into the other reservoir 22. Particles pass through with the electrolyte, and (since they have a lower conductivity than the electrolyte) cause an increase in the resistance of the pore which varies the voltage detected by the third electrode.The precise form of the voltage change depends upon the application:
- if biological cells are to be analysed for their
deformability and volume, then the system will be
arranged such that the diameter of the first part of
the pore is significantly smaller than that of the
cell, for example 3 to 5 micrometres for red blood
cells, so that the cell must deform in order to pass
through. A typical trace for the change in voltage
detected between the third and second electrodes
during the passage of a blood cell is illustrated in
Figure 4. The voltage V is steady at its resting level until the cell enters portion A. The cell takes a finite time to squeeze through the narrow pore portion, and effectively occludes it, causing its resistance RA to rise substantially, reducing the voltage V to near zero.As the cell emerges from portion A into portion B, which has a larger diameter than the cell, it causes a smaller increase in resistance RB so that voltage V rises above the steady state level. The difference in voltage above the steady-state level is a measure of the volume of the cell.
- if the number and size of small particles is to be determined, the system will be arranged so that the pore size used is such that the expected particle size range of interest lies within 2-60% of the pore diameter. In this case, the change in resistance RA is not so large as if the pore was completely occluded, and the difference in voltage below the steady-state level is a measure of the volume of the particle. Similarly, when the particle enters region
B, the difference in voltage above the steady-state level is again a measure of the particle volume. Also, since each particle passing through a pore causes a change in voltage, the number of particles can easily be counted.For this application, the particles might also be propelled through the pores by electrophoretic or electro-osmotic potentials instead, or in addition to,, the trans-membrane pressure difference.
ADVANTAGES:
The specific advantages of this device arise from the independence of each pore in the membrane, which may be considered to comprise a large number of detectors operating in parallel. They are: 1) In respect of its use for particle counting and size analysis:
(i) NOISE REDUCTION:
The present device mitigates the problem of electrical
noise and vibration by the use of multiple independent
pores as apertures. A number (probably 30-50,
possibly many more) of these pores, of suitable
diameter, are preferably arranged to be physically
close together in the membrane. In this situation,
any external influences, such as electrical noise and
vibration, will affect each pore in a similar manner.
A spurious signal arising as a consequence of noise
will be detected in the output from the probe
electrode of many or all of these pores. However,
when a particle passes through a pore, it is only the
output from that pore which is affected. This valid
signal may therefore be extracted from the noise by
comparing the output from an individual pore with that
from its surrounding neighbours. There are various
ways to achieve this; for example subtraction from
the occupied pore's signal of an averaged background
signal derived from the unoccupied pores, or by simply
disregarding the signal from the occupied pore if a
simultaneous spurious signal is detected in the
unoccupied pores.
(ii) REDUCTION OF THE CONSEQUENCES OF APERTURE
BLOCKAGE: Aperture occlusion, either partial or
total, can cause much difficulty in the known aperture
impedance technique. With the present device, such
occlusion is easily detected by a permanent change in
the output level of the pore affected, and any
subsequent signal from that pore is then disregarded.
Because of the large number of independent pores there
is a high degree of redundancy, and many may be
allowed to become occluded before the operation must
be abandoned and the pores cleared.
(iii) A range of different pore sizes may be
incorporated into a single device in order to increase
the size range of particles measurable. For example,
the device may incorporate ten 50 micrometre pores
together with one hundred of 5 micrometre diameter.
2) In respect of its use for blood cell deformability determination:
i) High cell concentrations may be used, because the
system is indifferent to the simultaneous presence of
cells in two or more pores, which leads in turn to a
high rate of data acquisition.
ii) Permanent pore blockage, or cells with long
transit times, present no difficulty because of the pore independence; a blocked pore will not affect the output from any of the others which will still operate normally.
iii) A series of pores having different sizes and cross-sectional shapes may be incorporated into a single membrane. For example, one might wish to use a set of pores of 2,4,6,8, and 10 micrometre diameter, perhaps ten of each size; or possibly relatively more of the smaller sizes to compensate for the longer transit times. Alternatively, different cross-sectional shapes could be used in order to obtain some information about the relative contributions of the cell membrane and cytoplasm to the deformation.
iv) The size of each cell can be measured as well as its transit time. The combination of these two parameters is particularly valuable, because it is well established that the passage of cells through pores depends both upon the overall flexibility and the cell volume.
v) Errors in the output due to external influences, such as electrical noise and vibration, may be eliminated as described in the previous section.
Claims (9)
1. An apparatus for counting particles and for determining their volume and deformability which comprises: - a membrane having a first reservoir on one side thereof
containing a first electrode and a second reservoir on
the other side thereof containing a second electrode; - the membrane having a plurality of pores therethrough,
which provide in use the only means for establishing
electrical continuity between the first and second electrodes
via electrically conductive liquid contained in the reser
voirs, each pore comprising a first portion leading into
a second portion; and - a respective third electrode being located at the junction
of the first and second portions of each pore, in use
the changes in electrical potential sensed at the respective
third electrode being indicative of the presence of a par
ticle within the pore, the size of the particle, and its
transit time within each portion of the pore.
2. An apparatus according to Claim 1 in which the resistence of any pore portion is sufficient to provide a measureable voltage drop between the third electrode and both the first and second electrodes when no particle is present.
3. An apparatus according to Claim 2 in which the pore portions are of equal length and diameter.
4. An apparatus according to Claim 2 in which the first pore portion is narrower and shorter, whilst the second pore portion is wider and longer.
5. An apparatus according to any of the preceding Claims in which the membrane is formed from a sandwich of two electrically insulating materials between which are sandwiched the third electrodes and their associated leads.
6. An apparatus according to Claim 5 in which the third electrodes and the pores may be fabricated by electron beam lithography.
7. A method for counting particles and for determining their volume and deformability in which: - a suspension of the particles or cells in a suitable conduc
ting electrolyte solution is placed in one or other of the
reservoirs, with identical particle-free solution placed
in the other; - a pressure difference is applied across the membrane
to induce the flow of the liquid containing the suspended
particles or cells into and through the pores (this pressure
depends upon the application, but it typically in the
range of 0.1 to 30 millibar); and - the electrical potentials sensed at the respective third
electrodes are fed into a signal processing device pro
grammed to extract relevant parameters according to the
particular application (such as transit times and voltage
changes) and to convert these into the number of particles
and their volumes, or the size and deformability of cells.
8. An apparatus for counting particles and for determining their volume and deformability substantially as described herein with reference to and as illustrated in the accompanying drawings.
9. A method for counting particles and for determining their volume and deformability, substantially as described herein with reference to and as illustrated in the accompanying drawings.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8913593A GB2232769B (en) | 1989-06-13 | 1989-06-13 | Counting and volume measurement of particles and biological cells,and determination of their deformability |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8913593A GB2232769B (en) | 1989-06-13 | 1989-06-13 | Counting and volume measurement of particles and biological cells,and determination of their deformability |
Publications (3)
Publication Number | Publication Date |
---|---|
GB8913593D0 GB8913593D0 (en) | 1989-08-02 |
GB2232769A true GB2232769A (en) | 1990-12-19 |
GB2232769B GB2232769B (en) | 1994-06-22 |
Family
ID=10658373
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB8913593A Expired - Fee Related GB2232769B (en) | 1989-06-13 | 1989-06-13 | Counting and volume measurement of particles and biological cells,and determination of their deformability |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2232769B (en) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5376878A (en) * | 1991-12-12 | 1994-12-27 | Fisher; Timothy C. | Multiple-aperture particle counting sizing and deformability-measuring apparatus |
EP0682241A1 (en) * | 1994-05-09 | 1995-11-15 | Toa Medical Electronics Co., Ltd. | Particle measuring apparatus and particle measuring method by the apparatus |
EP0815438A1 (en) * | 1995-03-17 | 1998-01-07 | President And Fellows Of Harvard College | Characterization of individual polymer molecules based on monomer-interface interactions |
WO2001023865A1 (en) * | 1999-09-28 | 2001-04-05 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Device and method for characterizing spheroids |
US6362002B1 (en) | 1995-03-17 | 2002-03-26 | President And Fellows Of Harvard College | Characterization of individual polymer molecules based on monomer-interface interactions |
US6627067B1 (en) | 1999-06-22 | 2003-09-30 | President And Fellows Of Harvard College | Molecular and atomic scale evaluation of biopolymers |
WO2003020125A3 (en) * | 2001-08-30 | 2003-11-27 | Fraunhofer Ges Forschung | Device and method for detecting bioelectric signals from electrophysiologically active regions in spheroids |
WO2003104770A3 (en) * | 2002-06-11 | 2004-11-11 | Chempaq As | A disposable cartridge for characterizing particles suspended in a liquid |
US7238485B2 (en) | 2004-03-23 | 2007-07-03 | President And Fellows Of Harvard College | Methods and apparatus for characterizing polynucleotides |
US7846738B2 (en) | 2003-08-15 | 2010-12-07 | President And Fellows Of Harvard College | Study of polymer molecules and conformations with a nanopore |
US8028566B2 (en) | 2005-02-10 | 2011-10-04 | Chempaq A/S | Dual sample cartridge and method for characterizing particles in liquid |
US8573033B2 (en) | 2005-02-10 | 2013-11-05 | Koninklijke Philips N.V. | Method for characterizing particles in liquid using a dual sample cartridge |
US8828211B2 (en) | 2010-06-08 | 2014-09-09 | President And Fellows Of Harvard College | Nanopore device with graphene supported artificial lipid membrane |
US8986528B2 (en) | 1995-03-17 | 2015-03-24 | President And Fellows Of Harvard College | Characterization of individual polymer molecules based on monomer-interface interactions |
CN106442275A (en) * | 2016-09-18 | 2017-02-22 | 中国人民武装警察部队总医院 | Method and kit for qualitatively detecting chyle |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1456599A (en) * | 1973-10-12 | 1976-11-24 | Us Energy Research Dev Adminis | Potential sensing cell analyzer |
US4055799A (en) * | 1975-01-23 | 1977-10-25 | Kernforschungsanlage Julich Gesellschaft Mit Beschrankter Haftung | Method of and device for measuring elastic and di-electric properties of the diaphragm of living cells |
GB1602134A (en) * | 1977-06-27 | 1981-11-04 | Contraves Ag | Particle analysis |
US4438390A (en) * | 1981-03-23 | 1984-03-20 | Coulter Electronics, Inc. | Tandem sensing zones for improved signal-to-noise ratio in particle analyzer |
GB2163555A (en) * | 1984-08-24 | 1986-02-26 | Descartes Universite Rene | Apparatus and process for determining the deformability of the red corpuscles in the blood |
-
1989
- 1989-06-13 GB GB8913593A patent/GB2232769B/en not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1456599A (en) * | 1973-10-12 | 1976-11-24 | Us Energy Research Dev Adminis | Potential sensing cell analyzer |
US4055799A (en) * | 1975-01-23 | 1977-10-25 | Kernforschungsanlage Julich Gesellschaft Mit Beschrankter Haftung | Method of and device for measuring elastic and di-electric properties of the diaphragm of living cells |
GB1602134A (en) * | 1977-06-27 | 1981-11-04 | Contraves Ag | Particle analysis |
US4438390A (en) * | 1981-03-23 | 1984-03-20 | Coulter Electronics, Inc. | Tandem sensing zones for improved signal-to-noise ratio in particle analyzer |
GB2163555A (en) * | 1984-08-24 | 1986-02-26 | Descartes Universite Rene | Apparatus and process for determining the deformability of the red corpuscles in the blood |
Cited By (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5376878A (en) * | 1991-12-12 | 1994-12-27 | Fisher; Timothy C. | Multiple-aperture particle counting sizing and deformability-measuring apparatus |
EP0682241A1 (en) * | 1994-05-09 | 1995-11-15 | Toa Medical Electronics Co., Ltd. | Particle measuring apparatus and particle measuring method by the apparatus |
US5623200A (en) * | 1994-05-09 | 1997-04-22 | Toa Medical Electronics Co., Ltd. | Particle measuring apparatus and particle measuring method by the apparatus |
US6362002B1 (en) | 1995-03-17 | 2002-03-26 | President And Fellows Of Harvard College | Characterization of individual polymer molecules based on monomer-interface interactions |
EP0815438A4 (en) * | 1995-03-17 | 2001-04-18 | Harvard College | Characterization of individual polymer molecules based on monomer-interface interactions |
US6673615B2 (en) | 1995-03-17 | 2004-01-06 | President And Fellows Of Harvard College | Characterization of individual polymer molecules based on monomer-interface interactions |
US9046483B2 (en) | 1995-03-17 | 2015-06-02 | President And Fellows Of Harvard College | Characterization of individual polymer molecules based on monomer-interface interactions |
US7189503B2 (en) | 1995-03-17 | 2007-03-13 | President And Fellows Of Harvard College | Characterization of individual polymer molecules based on monomer-interface interactions |
US8986528B2 (en) | 1995-03-17 | 2015-03-24 | President And Fellows Of Harvard College | Characterization of individual polymer molecules based on monomer-interface interactions |
EP1956367A1 (en) * | 1995-03-17 | 2008-08-13 | President And Fellows Of Harvard College | Characterization of individual polymer molecules based on monomer-interface interactions |
EP0815438A1 (en) * | 1995-03-17 | 1998-01-07 | President And Fellows Of Harvard College | Characterization of individual polymer molecules based on monomer-interface interactions |
US6627067B1 (en) | 1999-06-22 | 2003-09-30 | President And Fellows Of Harvard College | Molecular and atomic scale evaluation of biopolymers |
WO2001023865A1 (en) * | 1999-09-28 | 2001-04-05 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Device and method for characterizing spheroids |
US7709246B2 (en) * | 2001-08-30 | 2010-05-04 | Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Forshung E.V. | Device and method for detecting bioelectric signals from electrophysiologically active regions in spheroids |
WO2003020125A3 (en) * | 2001-08-30 | 2003-11-27 | Fraunhofer Ges Forschung | Device and method for detecting bioelectric signals from electrophysiologically active regions in spheroids |
US8227250B2 (en) | 2002-06-11 | 2012-07-24 | Koninklijke Philips Electronics N.V. | Lysing reagent, cartridge and automatic electronic cell counter for simultaneous enumeration of different types of white blood cells |
US7797990B2 (en) | 2002-06-11 | 2010-09-21 | Chempaq A/S | Disposable cartridge for characterizing particles suspended in a liquid |
US7771658B2 (en) | 2002-06-11 | 2010-08-10 | Chempaq A/S | Disposable cartridge for characterizing particles suspended in a liquid |
WO2003104770A3 (en) * | 2002-06-11 | 2004-11-11 | Chempaq As | A disposable cartridge for characterizing particles suspended in a liquid |
US8394640B2 (en) | 2003-08-15 | 2013-03-12 | President And Fellows Of Harvard College | Study of polymer molecules and conformations with a nanopore |
US7846738B2 (en) | 2003-08-15 | 2010-12-07 | President And Fellows Of Harvard College | Study of polymer molecules and conformations with a nanopore |
US8969091B2 (en) | 2003-08-15 | 2015-03-03 | President And Fellows Of Harvard College | Study of polymer molecules and conformations with a nanopore |
US7947454B2 (en) | 2004-03-23 | 2011-05-24 | President And Fellows Of Harvard College | Methods and apparatus for characterizing polynucleotides |
US8673556B2 (en) | 2004-03-23 | 2014-03-18 | President And Fellows Of Harvard College | Methods and apparatus for characterizing polynucleotides |
US7625706B2 (en) | 2004-03-23 | 2009-12-01 | Agilent Technologies, Inc. | Methods and apparatus for characterizing polynucleotides |
US7238485B2 (en) | 2004-03-23 | 2007-07-03 | President And Fellows Of Harvard College | Methods and apparatus for characterizing polynucleotides |
US8573033B2 (en) | 2005-02-10 | 2013-11-05 | Koninklijke Philips N.V. | Method for characterizing particles in liquid using a dual sample cartridge |
US8028566B2 (en) | 2005-02-10 | 2011-10-04 | Chempaq A/S | Dual sample cartridge and method for characterizing particles in liquid |
US8828211B2 (en) | 2010-06-08 | 2014-09-09 | President And Fellows Of Harvard College | Nanopore device with graphene supported artificial lipid membrane |
US9797863B2 (en) | 2010-06-08 | 2017-10-24 | President And Fellows Of Harvard College | Graphene supported artificial membranes and uses thereof |
CN106442275A (en) * | 2016-09-18 | 2017-02-22 | 中国人民武装警察部队总医院 | Method and kit for qualitatively detecting chyle |
Also Published As
Publication number | Publication date |
---|---|
GB2232769B (en) | 1994-06-22 |
GB8913593D0 (en) | 1989-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5376878A (en) | Multiple-aperture particle counting sizing and deformability-measuring apparatus | |
GB2232769A (en) | Counting, volume and deformability measurement of particles and biological cells | |
EP0092775B1 (en) | Device for the measurement of erythrocyte deformability | |
EP0368241B1 (en) | Blood filter, method and apparatus for hemorheological measurement | |
JP2965688B2 (en) | Particle detector | |
US6426615B1 (en) | Apparatus and method for analyzing particles | |
US7417418B1 (en) | Thin film sensor | |
US7242474B2 (en) | Cytometer having fluid core stream position control | |
US4165484A (en) | Particle counting apparatus utilizing various fluid resistors to maintain proper pressure differentials | |
US4835457A (en) | Apparatus and process for determining the deformability of the red corpuscles in the blood | |
JP3069795B2 (en) | Leukocyte measurement device | |
JPH0575352B2 (en) | ||
KR890700829A (en) | Multi-part classification analysis device using light scattering technology | |
Koutsouris et al. | Determination of erythrocyte transit times through micropores. I-Basic operational principles | |
CN107209098A (en) | Diagnosing chip | |
EP0187663B1 (en) | Particle detector | |
US4103229A (en) | Continuous-flow, resistive-particle counting apparatus | |
US20220050042A1 (en) | Impedance flow cytometry apparatus | |
US4240029A (en) | Apparatus for counting particles in a liquid suspension | |
US4375615A (en) | Apparatus for counting particles in a liquid suspension | |
Roberts et al. | A silicon microfabricated aperture for counting cells using the aperture impedance technique | |
JPS627966B2 (en) | ||
JP4366327B2 (en) | Micro Coulter Counter | |
Grover et al. | Electrical sizing of cells in suspension | |
Leif et al. | The automated multiparameter analyzer for cells (AMAC) IIA, a true bridge circuit Coulter-type electronic cell volume transducer. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 19960613 |